Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RVT-1601
RVT-1601
Roivant launches lung-focused Respivant with phase 2 IPF drug
Fierce Biotech
Tue, 09/18/18 - 10:12 am
Roivant
Respivant Sciences
IPF
RVT-1601